Naistentautien ja synnytysten vastuualue

Julkaisut 2016 (alustava)
Publications 2016 (preliminary)

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aaltonen R, Nieminen K. Synnytinelinlaskeuman toteaminen ja hoito.
2 Asadi-Azarbaijani B et al. Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro.
3 Colombo N et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
4 Du BOIS A et al. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
5 Gidwani K et al. A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.
6 Heinonen P. Twin pregnancy in the congenital malformed uterus.
7 Heinonen P. Distribution of female genital tract anomalies in two classifications.
8 Hämäläinen S et al. Raskaushepatoosi -hankala, mutta ohimeneva vaiva.
9 Jalkanen V et al. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Are Elevated in Severe Pre-Eclampsia.
10 Jernman R et al. Anti-Ula as the Cause of Severe Hemolytic Disease of the Fetus and Newborn: A Case Report.
11 Kaartinen N. The Effect of Embryo Culture Length and Freezing Method on the ART Success Rate and the Weight of the Newborn.
12 Kaartinen N et al. The freezing method of cleavage stage embryos has no impact on the weight of the newborns.
13 Kruit H et al. Foley Catheter or Oral Misoprostol for Induction of Labor in Women with Term Premature Rupture of Membranes: A Randomized Multicenter Trial.
14 Kuitunen I et al. Äidin ja vastasyntyneen hoito potilashotellissa.
15 Kupari M et al. Does an increased cesarean section rate improve neonatal outcome in term pregnancies?
16 Luhtala S et al. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
17 Mansikkamäki K et al. Hot flushes among aging women: A 4-year follow-up study to a randomised controlled exercise trial.
18 Mäenpää J et al. The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study.
19 Mäenpää M et al. Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial.
20 Nieminen K. Synnytysten keskittäminen lisää turvallisuutta.
21 Palomäki O, Volmanen P. Alternative neural blocks for labour analgesia.
22 Pasanen A et al. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
23 Pokkinen S et al. Characterization of persistent pain after hysterectomy based on gynaecological and sensory examination.
24 Rodriguez-Wallberg K et al. Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries - compilation of 20 years of multicenter experience.
25 Seikkula J et al. Effect of mid-luteal phase GnRH agonist on frozen-thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study.
26 Soini T et al. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
27 Soini T et al. Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study.
28 Staff S et al. Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study.
29 Staff S et al. Repeated intermittent use of ulipristal acetate associated with rapid growth and multilocular cystic hydropic degeneration of a uterine fibroid: A case report .
30 Suomalainen P et al. Traumakäsikirja, Vaikeasti vammautuneen potilaan hoito Taysissa 2016.
31 Toivonen E et al. Cardiotocography in breech versus vertex delivery: an examiner-blinded, cross-sectional nested case-control study.
32 Uotila J, Nieminen K. Yhteinen puhelinneuvonta äitiyshuoltoon.
33 Vallius T et al. (18)F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
34 Veijalainen O et al. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
35 Veskimäe K et al. Assessment of PARP protein expression in epithelial ovariancancer by ELISA pharmacodynamic assayand immunohistochemistry.
36 Vilmi-Kerälä T et al. Oxidized LDL, insulin resistance and central blood pressure after gestational diabetes mellitus.
37 Virkki M et al. Käsitteet selkeiksi.
38 Virtanen A et al. Strong inhibitory effect of pre-eclampsia serum on angiogenesis detected in vitro by human cell-based angiogenesis tests.
Julkaisutietokanta 19.10.2017 Publications Data Base 19.10.2017